Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen Establishes Scientific Advisory Board

NEW YORK (GenomeWeb News) - Ciphergen Biosystems announced today that it is established a scientific advisory board to "assist in directing the company's product development strategies."
There are five members in the advisory board:
Robert Bast, vice president for translational research and a professor at the University of Texas MD Anderson Center is best known for developing the Ovarian  Cancer 125 monoclonal antibody that led to the production of the CA125 radioimmunoassay for the monitoring of epithelial ovarian cancer.
Danel Chan, a professor of pathology, oncology, urology, and radiology, and the director of the Center for Biomarker Discovery at the Johns Hopkins University School of Medicine is recognized for his work in finding and developing biochemical tumor markers, particularly for breast and prostate cancer.
Ian Jacobs, director of the Department of Gynecological Oncology and the Institute of Women's Health at University College London has conducted laboratory studies on the genetic basis of gynecological cancer, and headed the UK Collaborative Trial of Ovarian Cancer Screening involving 200,000 women in the UK.
Joyce Schwartz, vice president and chief laboratory officer of Quest Diagnostics is responsible for medical operations and medical quality for Quest's core laboratory testing business.
William Wallen is the senior vice president and chief scientific officer of Idexx Laboratories, a company that produces products and services for veterinary, food and water applications. Before joining Idexx, Wallen was senior vice president and head of the office of technology for the diagnostics division of Bayer Healthcare.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.